PATIENTS AT RISK OF CHEMOTHERAPY-ASSOCIATED TOXICITY IN SMALL CELL LUNG-CANCER

被引：43

作者：

MORITTU, L

EARL, HM

SOUHAMI, RL

ASH, CM

TOBIAS, JS

GEDDES, DM

HARPER, PG

SPIRO, SG

机构：

[1] UNIV COLL & MIDDLESEX SCH MED,DEPT ONCOL,91 RIDING HOUSE ST,LONDON W1P 8BT,ENGLAND

[2] LONDON CHEST HOSP,LONDON E2 9JX,ENGLAND

[3] GUYS HOSP,DEPT MED ONCOL,LONDON SE1 9RT,ENGLAND

[4] BROMPTON HOSP,LONDON SW3 6HP,ENGLAND

来源：

BRITISH JOURNAL OF CANCER | 1989年 / 59卷 / 05期

关键词：

D O I：

10.1038/bjc.1989.167

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：801 / 804

页数：4

共 12 条

[1]

ARBUCK SG, 1985, P AN M AM SOC CLIN, V4, P40

[2] COMBINED MODALITY INDUCTION THERAPY WITHOUT MAINTENANCE CHEMOTHERAPY FOR SMALL CELL-CARCINOMA OF THE LUNG [J].

FELD, R ;

EVANS, WK ;

DEBOER, G ;

QUIRT, IC ;

SHEPHERD, FA ;

YEOH, JL ;

PRINGLE, JF ;

PAYNE, DG ;

HERMAN, JG ;

CHAMBERLAIN, D ;

BROWN, TC ;

BAKER, MA ;

MYERS, R ;

BLACKSTEIN, ME ;

PRITCHARD, KI .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (04) :294-304

[3] THE SUPERIORITY OF COMBINATION CHEMOTHERAPY INCLUDING ETOPOSIDE BASED ON INVIVO CELL-CYCLE ANALYSIS IN THE TREATMENT OF EXTENSIVE SMALL-CELL LUNG-CANCER - A RANDOMIZED TRIAL OF 288 CONSECUTIVE PATIENTS [J].

HIRSCH, FR ;

HANSEN, HH ;

HANSEN, M ;

OSTERLIND, K ;

VINDELOV, LL ;

DOMBERNOWSKY, P ;

SORENSSON, S .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) :585-591

[4] EFFECT OF LIVER-FAILURE ON THE PHARMACOKINETICS OF CYCLOPHOSPHAMIDE [J].

JUMA, FD .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (05) :591-593

[5]

OSTERLIND K, 1983, CANCER RES, V43, P6085

[6]

PFLUGER KH, 1987, CANCER CHEMOTH PHARM, V20, P59

[7]

SESSA C, 1985, P AM ASSOC CANC RES, V26, pA604

[8]

SOUHAMI RL, 1984, BRIT MED J, V288, P1643, DOI 10.1136/bmj.288.6431.1643

[9]

SOUHAMI RL, 1985, CANCER RES, V45, P2878

[10]

SPIRO SG, 1908, IN PRESS BR J CANCER

← 1 2 →